Cosmetic Guidelines ( Annex I - VII )

User Rating: 5 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Active
 

Cosmetics Guidelines

Document Name Updated
Guidelines for Control of Cosmetic Products in Malaysia Feb-17
Annex I, Part 1: Illustrative List Of Cosmetic Products By Categories Feb-17
Annex I, Part 2: Non-Permissible Product Name For Cosmetic Product Feb-17
Annex I, Part 3: Charges For Quest Membership Feb-17
Annex I, Part 4: Manual For Quest3+ Online Submission For Cosmetic Notification Feb-17
Annex I, Part 5: List Of Types Of Changes For Notified Product Feb-17
Annex I, Part 6: Guidelines for Safety Assessment of Cosmetic Product Feb-17
Annex 1, Part 7: Cosmetic Labeling Requirements Feb-17
Annex 1, Part 8: Cosmetic Claims Guidelines Feb-17
Annex 1, Part 9: Guideline For Cosmetic Advertisement Feb-17
Annex 1, Part 10:Guideline For Cosmetic Good Manufacturing Practice Feb-17
Annex 1, Part 11: List Of Equivalent Cosmetic GMP Guidelines Feb-17
Annex 1, Part 12: Guideline For Product Information File (PIF) Feb-17
Annex 1, Part 13: Guide Manual For Adverse Event Reporting Feb-17
Annex 1, Part 14: Heavy Metal And Microbiological Test Limit For Cosmetic Product Feb-17
Annex 1, Part 15: Guideline For Sunscreen Product Jul-17
Annexe II: List of Substances which Must Not Form Part of the Composition of Cosmetic Products Jul-18
Annexe III, Part 1: List of Substances Which Cosmetic Products Must Not Contain Except Subject to Restrictions and Conditions Laid Down Jul-18
Annexe IV: List of Colouring Agent Allowed for Use in Cosmetic Products Jul-18
Annexe V: List of Excluded from the Scope of the Directive May-10
Annexe VI: List of Preservatives which Cosmetic Products May Contain Jul-18
Annexe VII: List of UV Filters which Cosmetic Products May Contain Jul-18

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Newsletter Subsription

Site Last Modified

  • Last Modified: Monday 10 December 2018, 14:32:16.
© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA